A 15 year old male with type 2 diabetic mellitus is found to have 24 hour urinary albumin ok 250 milligrams which of the following drugs may be used to retard the progression of renal disease
First, I need to recall the drugs used in diabetic nephropathy. For type 2 diabetes, the mainstay is managing both blood sugar and blood pressure. But specifically for kidney protection, certain drugs are known to reduce albuminuria and slow kidney disease progression.
ACE inhibitors and ARBs are the go-to medications here. They work by blocking the RAAS system, which reduces intraglomerular pressure and proteinuria. So, if the options include an ACE inhibitor or an ARB, that's likely the correct answer. Let's say the options are A: Metformin, B: Insulin, C: Lisinopril (ACE inhibitor), D: Hydrochlorothiazide. Then the correct answer would be C.
Metformin is a first-line for type 2 diabetes but doesn't protect the kidneys directly. Insulin helps control glucose but doesn't address the renal damage. Thiazides are diuretics used for hypertension but not specifically for kidney protection in diabetes. So the key is identifying the RAAS blocker.
Also, the urinary albumin level here is 250 mg, which is above the normal range (normal is <30 mg/24h), indicating microalbuminuria. The goal is to prevent progression to macroalbuminuria and end-stage renal disease. So using an ACE inhibitor or ARB is crucial here. Therefore, the correct drug would be an ACE inhibitor or ARB. If the options include either, that's the answer. Let me check the options again. If the correct answer is listed as an option, then that's it. Otherwise, maybe another drug like a sodium-glucose cotransporter-2 inhibitor (SGLT2i) is also used now, but traditionally, ACE/ARBs are the first line. So, if the options have an ACE inhibitor or ARB, that's the correct choice. The other options don't have the same renal protective effects. The clinical pearl here is that ACE inhibitors and ARBs are first-line for slowing diabetic nephropathy, regardless of blood pressure levels.
**Core Concept**
Diabetic nephropathy in type 2 diabetes requires renoprotective therapy. **ACE inhibitors (e.g., lisinopril)** and **ARBs (e.g., losartan)** are first-line to reduce albuminuria and slow kidney disease progression by inhibiting the **renin-angiotensin-aldosterone system (RAAS)**, lowering glomerular pressure, and reducing oxidative stress.
**Why the Correct Answer is Right**
ACE inhibitors block **angiotensin-converting enzyme**, preventing conversion of angiotensin I to angiotensin II. This reduces systemic and glomerular pressure, decreases sodium reabsorption (via aldosterone suppression), and directly mitigates podocyte injury. A 24-hour urinary albumin of 250 mg indicates **microalbuminuria**, and early RAAS inhibition is critical to prevent progression to macroalbuminuria and end-stage renal disease.
**Why Each Wrong Option is Incorrect**
**Option A:** Metformin